Description
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
Learning Objectives
Upon completion of this educational activity, learners will be able to:
– Describe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies
– Discuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis
– Discuss prognostic and predictive assays in patients with breast cancer
Program :
Items Included in the Purchase of this Course
– Inflammatory and Reactive Lesions, Contemporary Issues in Breast Core Needle Biopsies – Laura C. Collins, MD
– Low Grade Triple Negative Neoplasms & Classification and Management of LCIS – Stuart J. Schnitt, MD
– Diagnostic Agreement in Breast Pathology, Intraductal Proliferative Lesions, & Current Guidelines for ER, PR and – – HER2 Testing – Kimberly H. Allison, MD
– Challenging Fibroepithelial Lesions & Problematic Papillary Lesions – Edi Brogi, MD, PhD
– New Breast Cancer Prognostic and Predictive Factors & Spindle Cell Lesions – Ashley M. Cimino-Mathews, MD
– Pathologic Evaluation of Specimens After Neoadjuvant Therapy & Mucinous Lesions – Hannah Y. Wen, MD, PhD
– Digital Slide Review with ARS – Laura C. Collins, MD and Stuart J. Schnitt, MD
– Panel Discussion and Q & A
Original release date: June 15, 2022
Access to this course expires on: April 27, 2025
